期刊
JOURNAL OF MEDICAL GENETICS
卷 58, 期 3, 页码 196-204出版社
BMJ PUBLISHING GROUP
DOI: 10.1136/jmedgenet-2019-106756
关键词
genetics; clinical genetics; epilepsy and seizures; molecular genetics
资金
- Genome British Columbia
- Provincial Health Services Authority
- BC Children's and Women's Hospitals
- Provincial Medical Genetics Program
- BC Children's Hospital Pathology and Laboratory Medicine
- University of British Columbia
- BC Children's Hospital Intramural Funds
- Canadian Institutes of Health Research [PJT-148695, PJT-148830]
- BC Children's Hospital Foundation through their Investigator Grant Award Program (IGAP)
Rare coding variants in SETD1B can lead to a diagnosable syndrome with shared phenotype of intellectual disability, language delay, conserved musculoskeletal findings, and potentially treatment-refractory seizures. Next-generation sequencing among a cohort of paediatric patients with epilepsy provides supporting evidence for these findings, suggesting that these variants may contribute as a risk factor for epilepsy, autism, and other neurodevelopmental phenotypes. Longitudinal studies are needed to further understand the role of SETD1B in neurodevelopmental disorders and other systemic diseases.
Background Dysfunction of histone methyltransferases and chromatin modifiers has been implicated in complex neurodevelopmental syndromes and cancers. SETD1B encodes a lysine-specific methyltransferase that assists in transcriptional activation of genes by depositing H3K4 methyl marks. Previous reports of patients with rare variants in SETD1B describe a distinctive phenotype that includes seizures, global developmental delay and intellectual disability. Methods Two of the patients described herein were identified via genome-wide and exome-wide testing, with microarray and research-based exome, through the CAUSES (Clinical Assessment of the Utility of Sequencing and Evaluation as a Service) Research Clinic at the University of British Columbia. The third Vancouver patient had clinical trio exome sequencing through Blueprint Genetics. The fourth patient underwent singleton exome sequencing in Nantes, with subsequent recruitment to this cohort through GeneMatcher. Results Here we present clinical reports of four patients with rare coding variants in SETD1B that demonstrate a shared phenotype, including intellectual disability, language delay, conserved musculoskeletal findings and seizures that may be treatment-refractory. We include supporting evidence from next-generation sequencing among a cohort of paediatric patients with epilepsy. Conclusion Rare coding variants in SETD1B can cause a diagnosable syndrome and could contribute as a risk factor for epilepsy, autism and other neurodevelopmental phenotypes. In the long term, some patients may also be at increased risk for cancers and other complex diseases. Thus, longitudinal studies are required to further elucidate the precise role of SETD1B in neurodevelopmental disorders and other systemic disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据